MARGARET SPITZ to Promoter Regions, Genetic
This is a "connection" page, showing publications MARGARET SPITZ has written about Promoter Regions, Genetic.
Connection Strength
0.491
-
Myeloperoxidase promoter region polymorphism and lung cancer risk. Methods Mol Med. 2003; 75:121-33.
Score: 0.156
-
Association of a novel functional promoter variant (rs2075533 C>T) in the apoptosis gene TNFSF8 with risk of lung cancer--a finding from Texas lung cancer genome-wide association study. Carcinogenesis. 2011 Apr; 32(4):507-15.
Score: 0.068
-
Myeloperoxidase G-463A polymorphism and lung cancer: a HuGE genetic susceptibility to environmental carcinogens pooled analysis. Genet Med. 2007 Feb; 9(2):67-73.
Score: 0.052
-
Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer. Clin Cancer Res. 2006 Dec 15; 12(24):7329-38.
Score: 0.051
-
MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis. Carcinogenesis. 2006 Oct; 27(10):2028-33.
Score: 0.049
-
Methyl-CpG-binding domain 2: a protective role in bladder carcinoma. Cancer. 2004 May 01; 100(9):1853-8.
Score: 0.043
-
A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res. 2001 Nov 01; 61(21):7825-9.
Score: 0.036
-
172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. Carcinogenesis. 2007 May; 28(5):988-94.
Score: 0.013
-
E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer. Clin Genet. 2006 Sep; 70(3):240-5.
Score: 0.013
-
A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res. 2002 Sep 01; 62(17):4992-5.
Score: 0.010